TGTX - שווי שוק לנפח מכירות TG Therapeutics Inc

סמל מסחרי של TG Therapeutics Inc (TGTX)

Compliance with environmental waste disposal regulations at TG Therapeutics, Inc. (TGTX) laboratories correlates with price action. The company's industry-average P/S reflects a market valuation where the 10.90 metric indicates its value status. Revenue growth is based on the sale of treatments for multiple sclerosis and B-cell tumors. The primary drivers are the launch of Briumvi, the expansion of therapy, and the potential for mergers within the biotech sector.

שווי שוק להכנסות tgtherapeutics.com (TGTX): לתקופה 04.07.2022 - 16.11.2026

פילוחים אנליטיים של חברת TG Therapeutics, Inc. (TGTX)

- מחיר מניה ומחיר יעד קונצנזוס:
- סטטיסטיקת שווי שוק:
ניתוח כללי של החברה:TGTX - TG Therapeutics Inc
פריט של המותג TG Pharma

For TG Therapeutics, Inc. (TGTX), which develops oncology drugs using AI and automation, the price/sales ratio trend reflects the market's valuation of future sales potential. This metric is calculated as the ratio of market capitalization to total revenue, allowing investors to determine the premium paid for the business amid prolonged clinical trials, where actual income is limited by strict medical oversight.